# Detection of Flap Ischemia Using Interstitial Glucose Monitor

> **NCT02604069** · EARLY_PHASE1 · UNKNOWN · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 30 (estimated)

## Conditions studied

- Free Tissue Flaps

## Interventions

- **DEVICE:** Continuous Glucose Monitor

## Key facts

- **NCT ID:** NCT02604069
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2016-02
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-11-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02604069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02604069, "Detection of Flap Ischemia Using Interstitial Glucose Monitor". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02604069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*